NEW!

More documents

Recommendations

Info

Monday, April 18 Integrated Neuroscience Session I6 1:00 p.m.–5:30 p.m. Integrated Neuroscience Session S Future Directions and Challenges in Stroke Team Action Therapy (STAT) This program is offered in partnership with the Stroke and Vascular Neurology Section. Coordinators: Jeffrey L. Saver, MD, FAAN, and Joseph P. Broderick, MD, FAAN Program Description: The INS program will present current uncertainties and future directions in acute stroke treatment. The introduction of mobile units with CT scan capability has the potential to reduce the delay in administration of i.v. thrombolysis by 45 minutes. New devices for mechanical thrombectomy are advancing this form of therapy and the program will present the diversity of new devices and their optimal therapeutic utilization. Advances in neuroimaging with rapid display of arterial thrombus location and extent of the penumbra region are extending the range of thrombolysis and improving the outcome of thrombectomy while pushing further out the frontiers of action. The recent development of comprehensive stroke centers with telestroke technology, mobile units, new neuroimaging capabilities, and increasingly sophisticated thrombectomy devices are reducing the time-delay for therapeutic action while paradoxically creating geographical disparities in access to care. A call to action is needed to reduce disparities. Upon Completion: Participants should be able to identify clinically relevant differences in phenotype or risk factors between males and females with neurological diseases. Part I 1:00 p.m.–3:00 p.m. 1:00 p.m.–1:10 p.m. Introduction Jeffrey L. Saver, MD, FAAN, and Joseph P. Broderick, MD, FAAN 1:10 p.m.–1:45 p.m. Invited Speaker The STAT Ambulance in Motion: Should My Center Get One? James C. Grotta, MD, FAAN, Houston, TX 1:45 p.m.–1:50 p.m. I6.001 Data Blitz Gaze Deviation and Acute Stroke Care Strategies —Zaid Mahdi, Anup Kumar Trikannad Ashwini Kumar, Pratik Bhattacharya, Ramesh Madhavan 1:50 p.m.–1:55 p.m. I6.002 Data Blitz Comparison of Large Vessel Occlusion Prediction Scores —Toby Gropen, Amelia Boehme, Sheryl Martin-Schild, Karen Albright, Brian Perrin, Alyana Samai, Sammy Pishanidar, Nazli Janjua, Steven Levine, Ethan Brandler, Dov Rosenbaum 1:55 p.m.–2:05 p.m. Audience Q&A 2:05 p.m.–2:40 p.m. Invited Speaker New Developments in Acute Stroke Neuroimaging: Future Directions Gregory W. Albers, MD, Stanford, CA 2:40 p.m.–2:45 p.m. I6.003 Data Blitz Variability in Approach to Treatment of Acute Central Retinal Artery Occlusion in US Teaching Hospitals —Matthew Schrag, Teddy Youn, Morgan Patrylo, Joseph Schindler, Patrick Lavin, Howard Kirshner, David Greer 2:45 p.m.–2:50 p.m. I6.004 Data Blitz Intracranial Hemorrhage on Warfarin: Time to Reversal Is of the Essence — Chandan Mehta, Mathew Jones, Mauricio Ruiz Cuero, Jody Wellwood, Mohammed Rehman, Panayiotis Mitsias, Panayiotis Varelas 2:50 p.m.–3:00 p.m. Audience Q&A Guided Poster Rounds I6.001 Gaze Deviation and Acute Stroke Care Strategies —Zaid Mahdi, Anup Kumar Trikannad Ashwini Kumar, Pratik Bhattacharya, Ramesh Madhavan I6.002 Comparison of Large Vessel Occlusion Prediction Scores —Toby Gropen, Amelia Boehme, Sheryl Martin- Schild, Karen Albright, Brian Perrin, Alyana Samai, Sammy Pishanidar, Nazli Janjua, Steven Levine, Ethan Brandler, Dov Rosenbaum I6.003 Variability in Approach to Treatment of Acute Central Retinal Artery Occlusion in US Teaching Hospitals — Matthew Schrag, Teddy Youn, Morgan Patrylo, Joseph Schindler, Patrick Lavin, Howard Kirshner, David Greer I6.004 Intracranial Hemorrhage on Warfarin: Time to Reversal Is of the Essence —Chandan Mehta, Mathew Jones, Mauricio Ruiz Cuero, Jody Wellwood, Mohammed Rehman, Panayiotis Mitsias, Panayiotis Varelas 3:00 p.m.–3:30 p.m. I6.005 Time is Brain: Standardized Neuro-Interventional Thrombectomy Protocols Lead to Faster Recanalization Times —Donald Frei, Lisa Caputo, Kathryn McCarthy, Kristin Salottolo, David Bar-Or I6.006 Effect of Annual Hospital Procedure Volume on Outcomes After Mechanical Thrombectomy in Acute Ischemic Stroke Patients: An Analysis of 13,502 Procedures —Achint Patel, Harshil Shah, Abhishek Lunagariya, Sanjeeva Onteddu, Sonal Mehta I6.007 Arterial Recanalization in the Golden Hour of IV TPA Administration for Ischemic Stroke —Rodica Bernatowicz, Megan Donohue, Muhammad Hussain, Seby John, Dolora Wisco, Ken Uchino I6.008 ARTSS-2: Final Results of a Pilot, Phase IIb, Randomized, Multi-Center Trial of Argatroban in Combination with Recombinant Tissue Plasminogen Activator for Acute Stroke —Andrew Barreto, Gary Ford, Loren Shen, Chunyan Cai, Claudia Pedroza, Jon Tyson, Mohammad Rahbar, James Grotta I6.009 Early CT Changes in Patients Admitted for Thrombectomy: Intra- and Interrater Agreement and Systematic Review of the Literature —Naim Khoury, Robert Fahed, Francois Guilbert, Alexandre Poppe, Nicole Daneault, Behzad Farazin, Andre Durocher, Sylvain Lanthier, Hayet Boudjani, Daniel Roy, Alain Weill, Jean- Christophe Gentric, Andre Lima Batista, Laurent Letourneau-Guillon, Francois Bergeron, Marc-Antoine Henry, Tim E. Darsaut, Jean Raymond I6.010 Onset to Reperfusion Times Strongly Determine Clinical Outcome Across a Wide Range of ASPECTS Scores in Endovascular Ischemic Stroke Therapy —Joon-Tae Kim, Mayank Goyal, Vitor Pereira-Mendes, Alain Bonafe, Jan Gralla, Reza Jahan, Elad Levy, David Liebeskind, Jeffrey Saver Part II I6.011 Overcoming Barriers to Reduce Door to Needle Times in Acute Ischemic Stroke Patients: Field to CT —Spozhmy Panezai, Florence Chukwuneke, Audrey Arango, Jaskiran Brar, Joshua Daniel, Daniel Korya, Siddhart Mehta, Mohammad Moussavi, Jawad Kirmani I6.012 Symptomatic Cerebral Ischemia Associated with Intensive Blood Pressure Lowering Following Acute Intracerebral Hemorrhage —Natalie Organek, Megan Donohue, Lauren Gotterer, Ken Uchino I6.013 The DRAGON Score Predicts Functional Outcomes in Acute Ischemic Stroke Patients Receiving Both Intravenous Tissue Plasminogen Activator (IVtPA) and Endovascular Therapy —Noorie Pednekar, Jin Li, Richard Zeman, Rachel Lehrer, Parvinder Kaur, Amrita Anreja, Emiliya Melkumova, Akira Todo, John Wainwright, Rivkah Epstein, Ramandeep Sahni, Stephen Marks, Michael Stiefel 3:30 p.m.–5:30 p.m. 3:30 p.m.–4:05 p.m. Invited Speaker Mechanical Thrombectomy Devices: How Many Are There and Where Are We Going? Johanna Fifi, MD, New York, NY 4:05 p.m.–4:10 p.m. I6.005 Data Blitz Time is Brain: Standardized Neuro-Interventional Thrombectomy Protocols Lead to Faster Recanalization Times —Donald Frei, Lisa Caputo, Kathryn McCarthy, Kristin Salottolo, David Bar-Or 4:10 p.m.–4:15 p.m. I6.006 Data Blitz Effect of Annual Hospital Procedure Volume on Outcomes After Mechanical Thrombectomy in Acute Ischemic Stroke Patients: An Analysis of 13,502 Procedures —Achint Patel, Harshil Shah, Abhishek Lunagariya, Sanjeeva Onteddu, Sonal Mehta 4:15 p.m.–4:25 p.m. Audience Q&A 4:25 p.m.–5:00 p.m. Invited Speaker Minimizing Geographical Disparities in Acute Stroke Treatment Dawn O. Kleindorfer, MD, Cincinnati, OH 5:00 p.m.–5:05 p.m. I6.007 Data Blitz Arterial Recanalization in the Golden Hour of IV TPA Administration for Ischemic Stroke —Rodica Bernatowicz, Megan Donohue, Muhammad Hussain, Seby John, Dolora Wisco, Ken Uchino 5:05 p.m.–5:10 p.m. I6.008 Data Blitz ARTSS-2: Final Results of a Pilot, Phase IIb, Randomized, Multi-Center Trial of Argatroban in Combination with Recombinant Tissue Plasminogen Activator for Acute Stroke —Andrew Barreto, Gary Ford, Loren Shen, Chunyan Cai, Claudia Pedroza, Jon Tyson, Mohammad Rahbar, James Grotta 5:10 p.m.–5:20 p.m. Audience Q&A 5:20 p.m.–5:30 p.m. Conclusion 82 2016 AAN Annual Meeting Abstract Listing
Meeting Schedule 1:00 p.m.–5:30 p.m. I6 S Future Directions and Challenges in Stroke Team Action Therapy (STAT) I7 The Human Connectome: Implications for Clinical Neurology . . . . . . . . . 84 I8 Emerging Technologies for Neurological Research and Care: #Emerging-Tech #Neurologist @AAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85 C116 $ Clinical Uses of Botulinum Toxin for Dystonia Skills Workshop (registration required) Director: Diego Torres-Russotto, MD, Omaha, NE 2:00 p.m.–3:00 p.m. Health & Wellness Mindfulness Meditation for Healthcare Practitioners Director: Sarah Mulukutla, MD, MPH, Stamford, CT 3:00 p.m.–4:00 p.m. Health & Wellness “Physical Exercise and Cognitive Training in Neurology”—Exercise in Stroke Director: AM Barrett, MD, West Orange, NJ 3:30 p.m.–4:30 p.m. I The Future of Payment Director: Lyell K. Jones, MD, FAAN, Rochester, MN 3:30 p.m.–5:30 p.m. S24: Clinical Outcomes and Treatment Strategies in Multiple Sclerosis . . . . . . . . 86 S25: Movement Disorders: Huntington’s Disease . . . . . . . . . . . . . . . . . . 86 S26: Headache. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86 C117 Clinical Approach to Muscle Disease II Director: Andrew Mammen, MD, PhD, Baltimore, MD C118 Therapy in Neurology II Director: David W. Dodick, MD, Phoenix, AZ C119 Common Spine Disorders II: Treatment Director: J. D. Bartleson, MD, FAAN, Rochester, MN C120 Cerebrovascular Disease III: Acute Ischemic Stroke Director: Philip B. Gorelick, MD, MPH, FAAN, Grand Rapids, MI C121 Emotional Communication: Chalk Talk Director: Kenneth M. Heilman, MD, FAAN, Gainesville, FL C122 Nonmotor Manifestations of Parkinson’s Disease II Director: Charles H. Adler, MD, PhD, FAAN, Scottsdale, AZ C123 Status Epilepticus Director: Frank W. Drislane, MD, FAAN, Newton, MA C124 Core Concepts in Pain Management II: Safe Opioid Prescribing ? Practical Considerations, Unintended Consequences, and Legal Issues Director: James C. Watson, MD, Rochester, MN C125 Sleep for the Practicing Neurologist II: Sleep Duration, CNS Hypersomnias, and Treating Physician Fatigue Director: Michael J. Howell, MD, FAAN, Minneapolis, MN C126 Bedside Evidence-based Medicine: How to Find and Deconstruct Articles in Order to Take Care of Patients II (registration required) Director: Gary S. Gronseth, MD, FAAN, Kansas City, KS 4:00 p.m.–5:00 p.m. Health & Wellness Introduction to Stress Mastery—Going Beyond Stress Management Director: Ravinder Singh, MD, Beverly Hills, CA 4:30 p.m.–6:30 p.m. Exhibit Hall Opening Reception $ A registration fee is required L The program is one of the AAN Leadership University sessions S The course is part of a Subspecialty in Focus track I The program is one of the I Talk sessions Learning Lab The program is part of the Excitement of Discovery Experiential Learning Area Health & Wellness sessions Real World of Neurology Mon · April 18 Fast and easy registration · AAN.com/view/AM16 83
Page 1 and 2:
NEW! Dates • Format • Value SCI
Page 3 and 4:
See the value! 2015 Meeting Price 2
Page 5 and 6:
What’s Inside Table of Contents I
Page 7 and 8:
Meeting! INTRODUCTION See You in Va
Page 9 and 10:
Additional Information INTRODUCTION
Page 11 and 12:
OVERVIEWS Mon April 18 Tue April 19
Page 13 and 14:
Schedule Planning Forms Use the con
Page 15 and 16:
My Friday $ A registration fee is r
Page 17 and 18:
Hot Topics Plenary Session Friday,
Page 19 and 20:
$ A registration fee is required L
Page 21 and 22:
Meeting Schedule 6:30 a.m.-8:30 a.m
Page 23 and 24:
Poster Session Schedule and Floorpl
Page 25 and 26:
Meeting Schedule P1.029 Efficacy an
Page 27 and 28:
Presenters Stand by Posters 5:30 p.
Page 29 and 30:
Page 31 and 32:
Page 33 and 34: Presenters Stand by Posters 5:30 p.
Page 35 and 36: New Faculty and Trainee Reception!
Page 37 and 38: Meeting Schedule 11:30 a.m.-6:30 p.
Page 39 and 40: Saturday, April 16 1:00 p.m.-3:00 p
Page 41 and 42: Meeting Schedule 1:00 p.m.-5:30 p.m
Page 43 and 44: $ A registration fee is required L
Page 47 and 48: Meeting Schedule 6:30 a.m.-7:15 a.m
Page 59 and 60: Sunday, April 17 Scientific Platfor
Page 63 and 64: I5 1:00 p.m.-5:30 p.m. Integrated N
Page 65 and 66: Opening Party Experience New Ways t
Page 69 and 70: Don’t Forget to Visit the Exhibit
Page 79 and 80: P3.391 The Quix Test: A 30 Second T
Page 81 and 82: Annual Meeting App Now Available Th
Page 83: Meeting Schedule 9:00 a.m.-11:30 a.
Page 87 and 88: I8 1:00 p.m.-5:30 p.m. Integrated N
Page 89 and 90: Industry Therapeutic Updates Indust
Page 103 and 104: Frontiers in Neuroscience Plenary S
Page 125 and 126: Clinical Trials Plenary Session Wed
Page 131 and 132: Scientific Platform Sessions Meetin
Page 133 and 134: My Thursday $ A registration fee is
Page 135 and 136:
Meeting Schedule 6:30 a.m.-8:30 a.m
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Neurology Year in Review Plenary Se
Page 147 and 148:
Meeting Schedule 1:00 p.m.-3:00 p.m
Page 149 and 150:
1:00 p.m.-5:30 p.m. Integrated Neur
Page 151 and 152:
New Date and Time: CLOSING PARTY HA
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Association of Indian Neurologists
Page 161 and 162:
Potamkin Prize for Research in Pick
Page 163 and 164:
Cool An AAN initiative to help buil
Page 165 and 166:
Closing Party Happy Hour Thursday,
Page 167 and 168:
Annual Meeting Attendee Pricing: Go
Page 169 and 170:
Disclaimers/Disclosures Disclaimer
Page 171 and 172:
Hotel Reservations Why Book a Hotel
Page 173 and 174:
Sitka Sq Abbott St Ontario St Ontar
Page 175 and 176:
Luggage Restrictions for carry-on b
Page 177 and 178:
68 th Annual Meeting Exhibitors as
Page 179 and 180:
68 th Annual Meeting Planning Meeti
Page 181 and 182:
Jonathan S. Katz, MD Jori Fleisher,
Page 183 and 184:
AAN Leadership University courses a
show all

NEW!

Create successful ePaper yourself

Delete template?

Save as template?